[ad_1]
H. Cody Meissner
The AAP Infectious Disease Committee has updated its recommendations for the immunization of children and children for 2019 to include the use of live attenuated intranasal influenza vaccine, or LABA, in cases where a child would not otherwise vaccination.
In recent seasons, PAA has recommended inactivated influenza vaccine (ILV), given as an injection, compared to LAIV, as it has shown better results against the influenza A (H1N1) pdm09 virus.
"I think everyone is hopeful that the vaccine will work because the technology is attractive and some children prefer to get a nasal spray," H. Cody Meissner, MARYLAND, Professor of Pediatrics at Tufts Medical Center and AAP Consultant, said Infectious Diseases in Children. "It would be nice to have this vaccine as an option, but for now, the PAA suggests reserving LAIV for children who refuse a vaccine. It's better for a child to get a vaccine that may not work as well as stay unvaccinated. "
Meissner, who is also a Infectious Diseases in Children A member of the editorial board added that the revised AAP recommendation still differs from the CDC's recommendation to provide an influenza vaccine – IVI or LAIV – appropriate to the age and condition of the patient .
Each year, the Academy's recommendations for immunization are endorsed by the AAP, the CDC Advisory Committee on Immunization Practices, the American Academy of Family Physicians and the American College of Obstetricians and Gynecologists.
"I think the AAP hopes that the vaccine will work and that the data provided by the CDC this summer will demonstrate that FluMist is working better than in the past," Meissner said. "In this case, the AAP could consider a revised recommendation is consistent with the recommendation of the CDC." – by Katherine Bortz
Disclosure : Meissner does not report any relevant financial information.
[ad_2]
Source link
